Experts
Stories by Rachel Williamson
Health & Biotech
Bod makes $2.5m from Aussie pot buyers in the June quarter alone
Tech
Hydrix tries to cut through complexity with promises of $$$
Health & Biotech
COVID-19 adds $9bn to top four ASX health stocks
Health & Biotech
Health: Amplia really gives a FAK about cancer as phase 1 trial still on track
News
Freedom! Aussies plan to spend $$ on restaurants, holidays, manicures
Health & Biotech
Health: Immutep has dosed the last patient in one of its cancer studies
News
Australians reckon they’ll be fine, the economy not so much
Experts
Scopo’s health powerplays: Health goes up when markets go down
News
Fund managers should make friends with the millennial investor crowd
Health & Biotech
Check up: Diarrhoea and the FDA are lifting share prices
Health & Biotech